Castuner

DDReg Knowledge Capsule

DDReg Pharma

🎧 DDReg Knowledge Capsule Welcome to the DDReg Knowledge Capsule — your go-to podcast for concise, insightful conversations on the latest trends, innovations, and challenges in the life sciences industry. Brought to you by the experts at DDReg, this series distills complex regulatory affairs, pharmacovigilance, market access, and clinical development topics into easy-to-understand episodes. Subscribe now and empower your pharma journey, one capsule at a time.

Poddens webbplats

Lyssna i din app

Avsnitt

73 avsnitt

  1. Navigating Israel's 70 & 120-Day Fast-Track Drug Approvals 26:02
  2. Drug Registration in Spain: AEMPS Process & 2026 Timeline 14:01
  3. Winning AIFA Drug Reimbursement in Italy: Regulatory & HTA Roadmap 19:07
  4. Navigating EMA’s Voluntary Data Submission Pilot for NAMs 20:04
  5. Navigate German Nutraceutical & Novel Food Compliance 22:25
  6. Japan & Malaysia: Faster Clinical Trial Approvals? 🌏 21:25
  7. Global-to-Local Pharmacovigilance: Bridging Safety Gaps 21:53
  8. Realities of EAEU Pharmaceutical Registration 25:57
  9. Medical Device Registration in Kenya: Beyond Approval 17:48
  10. Dietary Supplement Registration in Brazil vs. Mexico ANVISA and COFEPRIS Market Entry Pathways 24:12
  11. Strategic Regulatory Intelligence: Turning Regulatory Signals into Product Decisions 20:35
  12. South Korea KDMF Requirements for Imported APIs 21:59
  13. Regulatory Data Quality: The Hidden Risk Behind Submission & Compliance 22:39
  14. Pharmacovigilance Launch Readiness For Marketing Authorization Holders 22:46
  15. The Strategic Role of Regulatory Affairs in Pharma Industry 21:01
  16. Global Biosimilar Pathways 2026 : US, EU, UK & Asia 18:48
  17. Registering Biosimilar Drugs with Health Canada 11:29
  18. Global Regulatory Operating Model For Pharma Leaders 21:28
  19. Mastering Global CMC Variations & Life Cycle Management 22:31
  20. Malaysia NPRA 2026: Fast Route for Biosimilar Registration 22:59
  21. Mandatory EUDAMED Compliance for German Medical Devices 2026 21:46
  22. India's Pharma Shift from Generics to Innovation 18:00
  23. Why Gene Therapy Manufacturing Fails FDA 17:44
  24. Navigating the UAE's MOHAP to EDE Transition 20:30
  25. Jordan Joins PICS Pharmaceutical Inspection Scheme 5:44
  26. AI in Regulatory Affairs: What It Can and Can’t Do in 2026 22:08
  27. NAFDAC Drug Registration: Nigeria Market Access Guide (2026) 21:23
  28. The RaaS Revolution in Pharma 2026 19:41
  29. Winning Thailand FDA Priority Drug Approvals 23:27
  30. Egypt EDA Drug Approval and Registration Guide 19:55
  31. Navigating TGA Australia Drug Registration and Compliance 25:53
  32. Global Orphan Drug Designations: Building a Cross-Market Strategy 22:10
  33. Sri Lanka’s 2026 Medical Device Regulatory Registration 21:11
  34. South Korea MFDS Drug Registration: 2026 Updates and Approval Guide 20:19
  35. 2026 SFDA Roadmap: Mastering Pharmaceutical Registration in Saudi Arabia 21:24
  36. How To Winning the ANVISA Drug Registration Race 18:42
  37. The Blueprint for Effective Pharmacovigilance SOPs 24:37
  38. Indonesia's Pharma Market: BPOM Drug Registration Decoded 21:10
  39. The WHO Global Strategy on Digital Health 2027 Framework 19:15
  40. Regulatory Impact of Manufacturing Site Transfers 18:18
  41. Post-Market Clinical Follow-Up: Regulatory Obligations and Documentation Strategies 20:58
  42. Ethnic Sensitivity Factors in Global Drug Development 16:36
  43. Mandating Bridging Studies Under ICH E5 Regulatory Criteria 17:43
  44. Cultural Nuances in Global Adverse Event Reporting 19:25
  45. Scaling Quality Compliance and Audits Across Global Networks 16:26
  46. 🧬 Clinical Trial Design Strategies for Advanced Therapies 13:51
  47. Advanced FMEA in Medical Device Lifecycle Management 13:32
  48. 10 Rules For 2026 Life Sciences Approvals 12:25
  49. FDA 510(k) Submission Process Guide for 2026 11:41
  50. AI Auditability: The Foundation of Digital Trust in Pharma 14:53